Reduced high-density lipoprotein 2b in non-obese type 2 diabetic patients analysed by a microfluidic chip method in a case-control study

Xunde Xian, Yahong Ma, Danhui D. Yang, Wei Huang, Yuhui Wang, Odilo Mueller, Elain Chang, Yves Konigshofer, Mark Van-Cleve, Jinkui Yang, George Liu

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Alterations in high-density lipoprotein (HDL) subfractions, especially in the HDL2b subfraction, have been reported in type 2 diabetes mellitus (T2DM). However, new methods for convenient and reliable quantitation of HDL2b are yet to be developed. Methods: Thirty-eight patients with T2DM were enrolled and age-, sex- and body mass index (BMI)-matched controls were selected from the same population. A microfluidic chip method was employed to analyse serum HDL subfractions. Results: The microfluidic chip method revealed a significant reduction in HDL2b and its ratio to total HDL in T2DM patients. There was a reverse correlation for total HDL and HDL2b, and its ratio with triglycerides, homeostasis model assessment-insulin sensitivity index (HOMA-IS) and insulin resistance index (HOMA-IR). Conclusions: We have shown a reduction of HDL2b and its ratio to total HDL by a novel chip method in T2DM patients. The significant correlation between HDL2b and HOMA-IS and HOMA-IR may have further predictive value in clinical utility.

Original languageEnglish (US)
Pages (from-to)619-623
Number of pages5
JournalBiomarkers
Volume14
Issue number8
DOIs
StatePublished - Dec 2009

Fingerprint

Microfluidics
HDL Lipoproteins
Case-Control Studies
Medical problems
Type 2 Diabetes Mellitus
Insulin Resistance
Insulin
Homeostasis
HDL2 Lipoprotein
Triglycerides
Body Mass Index
Serum
Population

Keywords

  • Bioanalyser
  • HDL subfractions
  • Microfluidic chip
  • Type 2 diabetes

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Health, Toxicology and Mutagenesis

Cite this

Reduced high-density lipoprotein 2b in non-obese type 2 diabetic patients analysed by a microfluidic chip method in a case-control study. / Xian, Xunde; Ma, Yahong; Yang, Danhui D.; Huang, Wei; Wang, Yuhui; Mueller, Odilo; Chang, Elain; Konigshofer, Yves; Van-Cleve, Mark; Yang, Jinkui; Liu, George.

In: Biomarkers, Vol. 14, No. 8, 12.2009, p. 619-623.

Research output: Contribution to journalArticle

Xian, X, Ma, Y, Yang, DD, Huang, W, Wang, Y, Mueller, O, Chang, E, Konigshofer, Y, Van-Cleve, M, Yang, J & Liu, G 2009, 'Reduced high-density lipoprotein 2b in non-obese type 2 diabetic patients analysed by a microfluidic chip method in a case-control study', Biomarkers, vol. 14, no. 8, pp. 619-623. https://doi.org/10.3109/13547500903204636
Xian, Xunde ; Ma, Yahong ; Yang, Danhui D. ; Huang, Wei ; Wang, Yuhui ; Mueller, Odilo ; Chang, Elain ; Konigshofer, Yves ; Van-Cleve, Mark ; Yang, Jinkui ; Liu, George. / Reduced high-density lipoprotein 2b in non-obese type 2 diabetic patients analysed by a microfluidic chip method in a case-control study. In: Biomarkers. 2009 ; Vol. 14, No. 8. pp. 619-623.
@article{6a06793edcab4cf49f278c5f9ea05028,
title = "Reduced high-density lipoprotein 2b in non-obese type 2 diabetic patients analysed by a microfluidic chip method in a case-control study",
abstract = "Background: Alterations in high-density lipoprotein (HDL) subfractions, especially in the HDL2b subfraction, have been reported in type 2 diabetes mellitus (T2DM). However, new methods for convenient and reliable quantitation of HDL2b are yet to be developed. Methods: Thirty-eight patients with T2DM were enrolled and age-, sex- and body mass index (BMI)-matched controls were selected from the same population. A microfluidic chip method was employed to analyse serum HDL subfractions. Results: The microfluidic chip method revealed a significant reduction in HDL2b and its ratio to total HDL in T2DM patients. There was a reverse correlation for total HDL and HDL2b, and its ratio with triglycerides, homeostasis model assessment-insulin sensitivity index (HOMA-IS) and insulin resistance index (HOMA-IR). Conclusions: We have shown a reduction of HDL2b and its ratio to total HDL by a novel chip method in T2DM patients. The significant correlation between HDL2b and HOMA-IS and HOMA-IR may have further predictive value in clinical utility.",
keywords = "Bioanalyser, HDL subfractions, Microfluidic chip, Type 2 diabetes",
author = "Xunde Xian and Yahong Ma and Yang, {Danhui D.} and Wei Huang and Yuhui Wang and Odilo Mueller and Elain Chang and Yves Konigshofer and Mark Van-Cleve and Jinkui Yang and George Liu",
year = "2009",
month = "12",
doi = "10.3109/13547500903204636",
language = "English (US)",
volume = "14",
pages = "619--623",
journal = "Biomarkers",
issn = "1354-750X",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Reduced high-density lipoprotein 2b in non-obese type 2 diabetic patients analysed by a microfluidic chip method in a case-control study

AU - Xian, Xunde

AU - Ma, Yahong

AU - Yang, Danhui D.

AU - Huang, Wei

AU - Wang, Yuhui

AU - Mueller, Odilo

AU - Chang, Elain

AU - Konigshofer, Yves

AU - Van-Cleve, Mark

AU - Yang, Jinkui

AU - Liu, George

PY - 2009/12

Y1 - 2009/12

N2 - Background: Alterations in high-density lipoprotein (HDL) subfractions, especially in the HDL2b subfraction, have been reported in type 2 diabetes mellitus (T2DM). However, new methods for convenient and reliable quantitation of HDL2b are yet to be developed. Methods: Thirty-eight patients with T2DM were enrolled and age-, sex- and body mass index (BMI)-matched controls were selected from the same population. A microfluidic chip method was employed to analyse serum HDL subfractions. Results: The microfluidic chip method revealed a significant reduction in HDL2b and its ratio to total HDL in T2DM patients. There was a reverse correlation for total HDL and HDL2b, and its ratio with triglycerides, homeostasis model assessment-insulin sensitivity index (HOMA-IS) and insulin resistance index (HOMA-IR). Conclusions: We have shown a reduction of HDL2b and its ratio to total HDL by a novel chip method in T2DM patients. The significant correlation between HDL2b and HOMA-IS and HOMA-IR may have further predictive value in clinical utility.

AB - Background: Alterations in high-density lipoprotein (HDL) subfractions, especially in the HDL2b subfraction, have been reported in type 2 diabetes mellitus (T2DM). However, new methods for convenient and reliable quantitation of HDL2b are yet to be developed. Methods: Thirty-eight patients with T2DM were enrolled and age-, sex- and body mass index (BMI)-matched controls were selected from the same population. A microfluidic chip method was employed to analyse serum HDL subfractions. Results: The microfluidic chip method revealed a significant reduction in HDL2b and its ratio to total HDL in T2DM patients. There was a reverse correlation for total HDL and HDL2b, and its ratio with triglycerides, homeostasis model assessment-insulin sensitivity index (HOMA-IS) and insulin resistance index (HOMA-IR). Conclusions: We have shown a reduction of HDL2b and its ratio to total HDL by a novel chip method in T2DM patients. The significant correlation between HDL2b and HOMA-IS and HOMA-IR may have further predictive value in clinical utility.

KW - Bioanalyser

KW - HDL subfractions

KW - Microfluidic chip

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=72949090336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72949090336&partnerID=8YFLogxK

U2 - 10.3109/13547500903204636

DO - 10.3109/13547500903204636

M3 - Article

C2 - 19747039

AN - SCOPUS:72949090336

VL - 14

SP - 619

EP - 623

JO - Biomarkers

JF - Biomarkers

SN - 1354-750X

IS - 8

ER -